Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (3158)	9/20/2005 8:32:44 PM
From: John McCarthy	Read Replies (2) \| Respond to of 12215

Wilder - please take a deep breath ... first so that you know ... I read your posts everyday .... right now I'm in this puppy around 40k shares ... I got in it for Memantine and, well, things changed I have dummed down (with intelluct I hope) the stroke trials as follows: American P3 trial .... Placebo ... 33% Ancrod .... 43% not a strong enough inducement to use European Trial .... cold blodded murder ....... EDIT - I will leave the bad spelling and not worth talking about ... (there was no precedent for what they did) and I don't want to go into it because its pointless This leads to my question ..... What bothers you about what was said at the nitt cc? Yes - your thoughts are important. regards, John